Showing results (1-10 of 86) with videos related to
Sort By:
Pageof 9
Muscle & Nerve|February 7, 2026
Generalizability of Edaravone EfficacyBenjamin Rix Brooks, David L Ennist, Danielle Beaulieu, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 12, 2021
Evidence for generalizability of edaravone efficacy using a novel machine learning risk-based subgroup analysis toolBenjamin Rix Brooks, Erik P Pioro, Danielle Beaulieu, et al.Muscle & Nerve|February 7, 2026
Study 19 (MCI186-19) Post Hoc AnalysesBenjamin Rix Brooks, Jeremy Shefner, Stephen AppleJournal of the Neurological Sciences|November 12, 2024
Efficacy of Radicava® IV (intravenous edaravone) in subjects with differing trajectories of disease progression in amyotrophic lateral sclerosis: Use of a novel statistical approach for post hoc analysis of a pivotal phase 3 clinical trialErik P Pioro, Benjamin Rix Brooks, Ying Liu, et al.Muscle & Nerve|August 1, 2023
The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosisBenjamin Rix Brooks, Erik P Pioro, Takeshi Sakata, et al.Drugs in R&D|June 20, 2022
Analysis of the US Safety Data for Edaravone (Radicava®) From the Third Year After LaunchAngela Genge, Benjamin Rix Brooks, Björn Oskarsson, et al.Plos One|June 14, 2022
Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]Benjamin Rix Brooks, Terry Heiman-Patterson, Martina Wiedau-Pazos, et al.Muscle & Nerve|November 24, 2021
Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS-R item scores in pivotal study MCI186-19Benjamin Rix Brooks, Erik P Pioro, Jonathan Katz, et al.Annals of Neurology|February 5, 2009
Managing amyotrophic lateral sclerosis: slowing disease progression and improving patient quality of lifeBenjamin Rix BrooksCNS Spectrums|April 12, 2007
Involuntary emotional expression disorder: treating the untreatedBenjamin Rix BrooksPageof 9